Drug
Ly3857210
Ly3857210: highest development phase Phase 2, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| LY3857210 NCT05620563 | Phase 2 | Osteoarthritis |
Latest
No recent events.
Follow Ly3857210 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.